Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.: right-to-reply

View at publisher Summarise with VIRAT
Authors: Sunish Shah, Clayton F Hausberger, Lingyi Peng, Goundappa K. Balasubramani, Ryan K. Shields
Cited by: 0
References: 13

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Response: We thank Tebano et al. for their important comments on our paper and we are cautious not to overinterpret results from our small study that did not yield a significant difference in treatment outcomes1,2 We observed that after propensity score weighting, patients with valvular endocarditis secondary to Enterobacterales (excluding Serratia spp.) who were treated with a combination antimicrobial regimen showed a trend towards lower 90-day mortality compared with those treated with monotherapy, and treatment emergent resistance was only observed in patients who received monotherapy.2 We agree that the decision to administer combination therapy for Enterobacterales endocarditis requires further exploration and that additional data are warranted. That said, this study was performed over a period of 24 years across a large health-system, which would emphasize the challenge of aggregating a larger sample size of patients with endocarditis secondary to Enterobacterales.2 Until larger studies or clinical trial data are available, administering combination antimicrobial therapy for valvular endocarditis secondary to Enterobacterales is not unreasonable. As noted, our data corroborates with a previous investigation demonstrating that treatment of Gram-negative endocarditis with the combination of a fluoroquinolone and beta-lactam was associated with decreased in-hospital mortality when compared with monotherapy and other antimicrobial regimen combinations.3 It is recognized that Enterobacterales were the most common aetiology of Gram-negative endocarditis.3

Fields of Study & Subjects

Infective Endocarditis Diagnosis and Management Ocular Infections and Treatments Cardiac Valve Diseases and Treatments

Publication details

Journal / source
Journal of Antimicrobial Chemotherapy
Volume
81
Issue
4
Pages
dkag121
Publication date
4 March 2026
Language
EN